Tibet Rhodiola Pharmaceutical Holding Co. Class ASSE: 600211

Full Text of 2023 Semi-annual Report

Aug 14, 2024 · Issued by Tibet Rhodiola Pharmaceutical Holding Co. Class A via Shanghai Stock Exchange

Full Text of 2023 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment